FNIII 14 Peptide

Product Description

FNIII 14 Peptide
Catalog number: B2014698
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 2 mg
Molecular Weight or Concentration: 2357 g/mol
Supplied as: Solid
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: TEATITGLEPGTEYTITYVIAL, Thr-Glu-Ala-Thr-Ile-Thr-Gly-Leu-Glu-Pro-Gly-Thr-Glu-Tyr-Thr-Ile-Thr-Tyr-Val-Ile-Ala-Leu, threonyl-α-glutamyl-alanyl-threonyl-isoleucyl-threonyl-glycyl-leucyl-α-glutamyl-prolyl-glycyl-threonyl-α-glutamyl-tyrosyl-threonyl-isoleucyl-threonyl-tyrosyl-valyl-isoleucyl-alanyl-leucine
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Julier Z, Martino MM, de Titta A, Jeanbart L, Hubbell JA. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine Sci Rep. 2015 Feb 24;5:8569.
2: Moulisová V, Gonzalez-García C, Cantini M, Rodrigo-Navarro A, Weaver J, Costell M, Sabater I Serra R, Dalby MJ, García AJ, Salmerón-Sánchez M. Engineered microenvironments for synergistic VEGF – Integrin signalling during vascularization Biomaterials. 2017 May;126:61-74.
3: Tarnovskaya S, Kiselev A, Kostareva A, Frishman D. Structural consequences of mutations associated with idiopathic restrictive cardiomyopathy Amino Acids. 2017 Nov;49(11):1815-1829.
4: De Laporte L, Rice JJ, Tortelli F, Hubbell JA. Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain PLoS One. 2013 Apr 18;8(4):e62076.
5: Russell TM, Delorey MJ, Johnson BJ. Borrelia burgdorferi BbHtrA degrades host ECM proteins and stimulates release of inflammatory cytokines in vitro Mol Microbiol. 2013 Oct;90(2):241-51.
6: Wijelath ES, Rahman S, Namekata M, Murray J, Nishimura T, Mostafavi-Pour Z, Patel Y, Suda Y, Humphries MJ, Sobel M. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism Circ Res. 2006 Oct 13;99(8):853-60.
7: Ikuta T, Sogawa N, Ariga H, Ikemura T, Matsumoto K. Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family Gene. 1998 Sep 14;217(1-2):1-13.
8: Johnson KJ, Sage H, Briscoe G, Erickson HP. The compact conformation of fibronectin is determined by intramolecular ionic interactions J Biol Chem. 1999 May 28;274(22):15473-9.
9: Yang F, West AP Jr, Allendorph GP, Choe S, Bjorkman PJ. Neogenin interacts with hemojuvelin through its two membrane-proximal fibronectin type III domains Biochemistry. 2008 Apr 8;47(14):4237-45.
10: Alvino CL, McNeil KA, Ong SC, Delaine C, Booker GW, Wallace JC, Whittaker J, Forbes BE. A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II J Biol Chem. 2009 Mar 20;284(12):7656-64.

Products Related to FNIII 14 Peptide can be found at Peptides